688089 Cabio Biotech(Wuhan)
- 15.98
- -0.47-2.86%
Cabio Biotech(Wuhan) News
Jia Biyou (688089.SH): Based on synthetic biology technology, the company has now developed a series of HMO products
Gelonghui, May 16, 丨 Jia Biyou (688089.SH) said on the investor interactive platform that with technological innovation as the fundamental driving force, the company has opened up the entire synthetic biology technology chain, gradually formed a biological data analysis and processing platform with computational biology and bioinformatics as the core technical capabilities, a biosynthetic platform with genetic engineering, metabolic engineering, enzyme engineering, and cell engineering as the core technical capabilities, and visual analysis of cell biology, biomedicine, and multidimensional omics as the core competencies. From product development to application technology, the company's synthetic biology research and development technology Capabilities have been further improved
Jia Biyou (688089.SH): Major customers have proposed clear plans to replace DHA in seaweed oil with DHA in fish oil, and the company is also actively participating
Gelonghui, May 16 | Jia Biyou (688089.SH) said on the investor interactive platform that the company's product pricing adopts the overall strategy of “one household, one policy, one product, one case”, and that there are differences in pricing for customers in different regions and application fields. In recent years, due to the influence of factors such as marine pollution and increased global ESG requirements, the global trend of replacing DHA in fish oil has accelerated. In the field of infant formula, major customers have proposed clear plans to replace DHA in seaweed oil with DHA in fish oil, and the company is also actively participating.
Jia Biyou (688089.SH): The company is based on synthetic biology
Gelonghui, May 16, 丨 Jia Biyou (688089.SH) said on the investor interactive platform that the company is based on synthetic biology. Currently, its main products include polyunsaturated fatty acid ARA, algae oil DHA, terpenoid substances beta-carotene, astaxanthin, etc., and the sugar substances SA and hMOS, etc., which are widely used in infant formula, health food, animal nutrition, personal care and beauty. It is also continuously expanding into biomedicine, biomaterials, biological agriculture, etc. based on the underlying technical characteristics of synthetic biology. field.
Jia Biyou (688089.SH) received a warning letter from the Hubei Securities Regulatory Bureau
Jia Biyou (688089.SH) announced that the company received it from the China Securities Regulatory Commission on May 15, 2024...
Jiabiyou (688089.SH) announced its 2023 annual results, with net profit of 91.3742 million yuan, an increase of 41.95% over the previous year
Jia Biyou (688089.SH) released its 2023 annual report. The company's revenue was 444 million yuan, compared with...
Shanxi Securities: Currently, the underlying technology of synthetic biology still has a lot of room for improvement, and product companies are easier to grow
The Zhitong Finance App learned that Shanxi Securities released a research report saying that currently there is still a lot of room for improvement in the underlying synthetic biology technology, the industry is still in the early stages of the life cycle, and product companies are more likely to grow. From a short-term perspective, product selection ability will have a critical impact on the short-term financial performance of product companies. Excellent products should have the two characteristics of “mature downstream application” and “cost leadership” to solve actual commercial needs: mature downstream applications: 1) the potential market is broad; 2) the demand is deterministic, and the market cost education is low. Cost leadership: The probability of technology implementation is high, and it has a cost advantage over existing alternative products. longterm
Jia Biyou (688089.SH): The trend of replacing fish oil with algae oil has gradually emerged in recent years
Gelonghui, March 19 | Jia Biyou (688089.SH) said on the investor interactive platform that the company currently produces algae oil DHA independently. After the fund-raising project is put into operation, the DHA oil production capacity can be increased from 150 tons to 600 tons. The powder production capacity is shared between ARA and DHA, and the total powder production capacity has also increased from 1,200 tons to 2,700 tons. Fish oil DHA and algae oil DHA each have obvious advantages in different application scenarios. Because seaweed oil DHA is produced in sealed fermenters through biological fermentation technology, the production process is clean, controllable and traceable, and is more environmentally friendly and safe, plus algae oil DH
Jia Biyou (688089.SH): Net profit increased 42.17% year on year in 2023
Gelonghui, Feb. 23: Jiabiyou (688089.SH) announced its 2023 annual performance report. In 2023, the company achieved operating income of 445,467,157.19 yuan, an increase of 2.78% over the same period last year; net profit attributable to owners of the parent company was 91,520,557.02 yuan, an increase of 42.17% over the same period last year; net profit attributable to owners of the parent company after deducting non-recurring gains and losses was 68,203,967.19 yuan, an increase of 121.88% over the same period last year. During the reporting period, new national standards for infant formula were implemented, and required
Jia Biyou (688089.SH): Net profit of 2023 was 91.56 million yuan, up 42.17% year on year
According to Zhitong Finance App News, Jia Biyou (688089.SH) released the 2023 annual performance report, with total operating revenue of 445 million yuan, up 2.78% year on year; net profit attributable to owners of the parent company was 91.56 million yuan, up 42.17% year on year; net profit attributable to owners of the parent company after deducting non-recurring profit and loss was 68.204 million yuan, up 121.88% year on year; basic earnings per share were 0.54 yuan. During the reporting period, new national standards for infant formula were implemented, and increased demand led to an increase in revenue for the company's ARA and DHA products. 2023
Jia Biyou (688089.SH): New hMOS series products developed using synthetic biology technology are accelerating industrialization
Gelonghui, Feb. 7 | Jia Biyou (688089.SH) said on the investor interactive platform that Jia Biyou is a company that develops and produces bio-based nutritional chemicals using synthetic biology as the underlying technology and cell factories as preparation methods. Since its establishment, the company has been deeply involved in the field of nutrition and health, gradually built a food safety and supply chain management system that meets international standards, and has become a core ingredient supplier to the global infant formula industry. Based on the three expansion strategies of “expanding to diversified application fields, expanding to diversified products, and expanding to the international market”, the company's main business is based on the rich academic functions of the product
Jia Biyou (688089.SH): The plan to increase the shareholders' holdings by a total of 3.8261 million yuan has been implemented
Gelonghui, Feb. 7 | Jia Biyou (688089.SH) announced that the company's director, Mr. Wang Huabiao, Director and Financial Director, Mr. Li Xiangyu, Deputy General Manager, Mr. Geng Anfeng, Deputy General Manager, Mr. Ma Tao, Deputy General Manager, Mr. Yi Huarong, and Supervisor Mr. Wu Yujun, intend to increase the company's shares through centralized bidding within 6 months from September 14, 2023 through the Shanghai Stock Exchange trading system. The cumulative increase ratio is not less than 187,000 shares. As of February 6, 2024, the entities that have increased their holdings have passed through the Shanghai Stock Exchange trading system to centralize bidding
GABIU (688089.SH): In view of recent Red Sea route matters, the company has planned cargo routes exported to Europe in advance
On December 25, Gelonghui (688089.SH) said on the investor interactive platform that if the company's cargo exported to Europe is shipped by sea, it will generally pass through the Red Sea route, but in view of recent Red Sea route matters, the company has already planned the cargo route exported to Europe in advance, which will not affect the normal delivery of products.
GABIU (688089.SH): DSM and the company cooperate on products such as ARA, algal oil DHA, and beta-carotene, and have mutual customer relationships
Glonghui, December 18|Jiabiyou (688089.SH) said on the investor interactive platform that DSM and the company cooperate in products such as ARA, algae oil DHA, and beta-carotene, and have a mutual customer relationship. The algae oil DHA foundry cooperation continues to advance in terms of technology, production capacity, standards, etc. Please pay attention to the company's regular reports on the cooperation in 2023. Please pay attention to the company's regular reports on the impact of this business on the company, and please read the announcement 2021-003. In addition, the company's algae oil DHA products have been evaluated and verified by the European Food Safety Authority's expert group on nutrition, novel food, and food allergens. The scientific opinion on safety is
Some directors and supervisors of Jiabiyou (688089.SH) increased their holdings of the company by a total of 112,600 shares
Jiabiyou (688089.SH) issued an announcement. As of December 4, some of the company's directors and supervisors have passed the Shanghai Stock Exchange...
GABIU (688089.SH): We think the application scenarios and market space of SA products are worth continuing to explore
Glonghui, November 21丨GABIU (688089.SH)'s recent investor relations activity record sheet shows that since this year, L'Oréal's Yuxi gilt bottle series upgrade products have added the company's SA products, which is a breakthrough in cosmetic application, driving and promoting the company's cooperation with other customers. At the same time, in terms of efficacy, the company discovered through research that SA is effective in promoting the production of type IV collagen. This discovery may provide strong support for the application of SA in cosmetics; in addition, the company team also gradually discovered that SA has the potential to be used in APIs. Overall, we think SA
Jabiyou (688089.SH): As a core product of omega-3 fatty acids, DHA products themselves have great potential for growth
Gelonghui, November 21|Jiabiyou (688089.SH)'s recent investor relations activity record table shows that DHA products, as the core products of omega-3 fatty acids, have great potential for growth. In the field of baby products, DHA products have shown a significant increase in sales volume since this year. Some major fish oil customers have also clarified plans to switch from fish oil DHA to algae oil DHA in the next two years, which is an important growth opportunity for the company; in the international market, it is also simultaneously promoting DHA's entry into the customer supply system; in the field of big health, the company has newly integrated big health teams, which is expected
GABIU (688089.SH): Several major overseas customers have begun to gradually increase volume, which is expected to be gradually reflected in the first half of next year
Gelonghui, November 21|Jiabiyou (688089.SH)'s recent investor relations activity record table shows that since the ARA patent expired, the company has continued to promote overseas market expansion, and some customers have achieved certain results. Starting in the third quarter of this year, several major overseas customers have gradually begun to increase volume, which is expected to be gradually reflected in the first half of next year; furthermore, the volume of overseas customer pickups in the first half of this year was affected by formula registration progress, and is expected to return to normal levels in the first half of next year.
Jiabiyou (688089.SH): The domestic prices of ARA products this year have been adjusted based on industry growth brought about by the new national standard
Gelonghui, November 21|Jiabiyou (688089.SH)'s recent investor relations activity record table shows that the domestic price of ARA products this year has been adjusted based on industry growth brought about by the new national standard. Currently, the company is still closely following and observing, and is currently unable to make a clear judgment on the price. At the same time, starting from the source of technology, the company is committed to reducing costs and increasing efficiency to serve customers and maintain the company's good profitability.
Jiabiyou (688089.SH): The new oil production capacity has now been fully put into use
Gelonghui, November 21|Jiabiyou (688089.SH)'s recent investor relations activity record table shows that the company's new production capacity is mainly divided into two projects: oil and powder. The new oil production capacity has now been fully put into use, and the new powder production capacity is limited by the progress of certification of products with new production capacity by major customers. Overall, it is later than expected. At present, the first batch of products produced by the company's new powder production capacity has been delivered to the customer's factory, and new product production is underway, awaiting feedback on the final product. Looking ahead to next year, the company is continuing to urgently promote the conversion of major customers, using customers with a good foundation of cooperation as a breakthrough to gradually increase the utilization of new powder production capacity
Jabiyou (688089.SH): Currently, the company's beta-carotene products are mainly sold to overseas markets
On November 9, Gelonghui (688089.SH) said on the Investor Interactive Platform, “Hello” and thank you for following the company. The company's beta-carotene products are high-purity natural products obtained through biological fermentation technology, mainly used in the fields of dietary supplements, health food, beauty and personal care. Currently, the company's beta-carotene products are mainly sold to overseas markets. Tomson Beijian Shijia has not yet added the company's products.
Analysis
Price Target
No Data
